Royal Bank of Canada
GDRX icon

Royal Bank of Canada’s GoodRx Holdings GDRX Stock Holding History

Royal Bank of Canada’s Portfolio GDRX Stock Details GDRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-17,400
Closed -$679K – 7548
2021
Q1 		$679K Buy
+17,400
New +$782K ﹤0.01% 3921

Other funds holding GDRX

FPM
Francisco Partners Management San Francisco, California $292M AUM 34.13% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
SLG
Silver Lake Group Menlo Park, California $3.68B AUM 7.22% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
PTC
Petrus Trust Company Dallas, Texas $915M AUM 2.95% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
PGCM
Prescott Group Capital Management Tulsa, Oklahoma $1.16B AUM 53.61% 1-Year Est. Return

Royal Bank of Canada's GDRX Position: Q1 2026 in Review

Royal Bank of Canada reduced its GoodRx Holdings (GDRX) stake by 31% in Q1 2026, selling an estimated $77.8K and leaving 75,243 shares worth $148K. The position accounts for ﹤0.01% of the portfolio, ranked #4900.

Royal Bank of Canada first reported a position in GDRX in Q3 2020 and has held it in 23 quarters since. The position peaked at $8.85M in Q1 2021. 175 funds tracked by Wall St. Rank hold GDRX as of Q1 2026.

  • Royal Bank of Canada held 75,243 shares of GoodRx Holdings worth $148K as of Q1 2026.
  • Royal Bank of Canada sold 33,169 GoodRx Holdings shares in Q1 2026, an estimated $77.8K.
  • GoodRx Holdings made up ﹤0.01% of Royal Bank of Canada's portfolio in Q1 2026, its #4900 holding.
  • Royal Bank of Canada first reported a position in GoodRx Holdings in Q3 2020 and has held it in 23 quarters since.
  • Royal Bank of Canada's GoodRx Holdings position peaked at $8.85M in Q1 2021.
  • 175 funds tracked by Wall St. Rank held GoodRx Holdings as of Q1 2026.

Based on Royal Bank of Canada's 13F filing for Q1 2026, filed 15 May 2026.